Skip to main content
Clinical Trials/EUCTR2020-004875-41-DK
EUCTR2020-004875-41-DK
Active, not recruiting
Phase 1

Opium tincture against chronic diarrhea - Healthy:An investigator initiated, randomized placebo-controlled, double-blinded, cross-over, clinical trial

Mech-Sense, Aalborg University Hospital0 sites20 target enrollmentStarted: October 12, 2020Last updated:

Overview

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Mech-Sense, Aalborg University Hospital
Enrollment
20

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Signed informed consent before any study specific procedures
  • Able to read and understand Danish
  • Male or female with an age of 20 years or more
  • The researcher believes that the participant understands what the study entails, are capable of following instructions, can attend when needed, and are expected to complete the study.
  • The investigator will ensure that fertile female participants have a negative pregnancy test before each treatment visit and use contraception during the entity of the study.
  • Opioid naïve\*
  • Healthy (assessed by a study\-affiliated medical doctor)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • Known allergy towards pharmaceutical compounds similar to Dropizol.
  • Participation in other studies within 14 days of first visit (1 year if opioids involved).
  • Expected need of medical/surgical treatment during the study
  • History of psychiatric illness (e.g. mental retardation, schizophrenia, affective disorders (depression), personality disorders or treatment with psychoactive medications)
  • History of substance abuse (e.g. alcohol, nicotine, THC, benzodiazepine, central stimulants and/or opioids)
  • Family history of substance abuse
  • Increased intracranial pressure
  • Known major stenosis of the intestines
  • Planned MRI within the next 3 months
  • Metal implants or pacemaker

Investigators

Sponsor
Mech-Sense, Aalborg University Hospital

Similar Trials